The Impact of Coronary Physiology on Contemporary Clinical Decision Making.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
27 07 2020
Historique:
received: 09 03 2020
revised: 13 04 2020
accepted: 21 04 2020
entrez: 25 7 2020
pubmed: 25 7 2020
medline: 20 1 2021
Statut: ppublish

Résumé

Physiological assessment of coronary artery disease (CAD) has become one of the cornerstones of decision making for myocardial revascularization, with a large body of evidence supporting the benefits of using fractional flow reserve and other pressure-based indexes for functional assessment of coronary stenoses. Furthermore, physiology allows the identification of specific vascular dysfunction mechanisms in patients without obstructive CAD. Currently, more than 10 modalities of functional coronary assessment are available, although the overall adoption of these physiological tools, of either intracoronary or image-based nature, is still low. In this paper the authors review these modalities of functional coronary assessment according to their timing of use: outside the catheterization laboratory, in the catheterization laboratory prior to the percutaneous coronary intervention (PCI), and in the catheterization laboratory during or after PCI. The authors discuss how the information obtained can be used in setting the indication for PCI, in planning and guiding the procedure, and in documenting the final functional result of the intervention. The advantages and limitations of each modality in each setting are discussed. Furthermore, the key value of intracoronary physiology in diagnosing mechanisms of microcirculatory dysfunction, which account for the presence of ischemia in many patients without obstructive CAD, is revisited. On the basis of the opportunities generated by the multiplicity of diagnostic tools described, the authors propose an algorithmic approach to physiological coronary investigations in clinical practice, with the key aims of: 1) avoiding unneeded revascularization procedures; 2) improving procedural PCI and long-term outcomes in patients with obstructive CAD; and 3) diagnosing vascular dysfunction mechanisms that can be effectively treated in patients with NOCAD. The authors believe that such structured approach may also contribute to the wider adoption of available technologies for functional assessment of patients with CAD.

Identifiants

pubmed: 32703589
pii: S1936-8798(20)31029-3
doi: 10.1016/j.jcin.2020.04.040
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1617-1638

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Norihiro Kogame (N)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands; Department of Cardiology, Toho University Medical Center, Ohashi Hospital, Tokyo, Japan.

Masafumi Ono (M)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Hideyuki Kawashima (H)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Mariusz Tomaniak (M)

Department of Cardiology, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands; First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Hironori Hara (H)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Jonathan Leipsic (J)

Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada.

Daniele Andreini (D)

Centro Cardiologico Monzino, IRCCS, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Carlos Collet (C)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Manesh R Patel (MR)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.

Shengxian Tu (S)

Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

Bo Xu (B)

Fu Wai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.

Christos V Bourantas (CV)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.

Amir Lerman (A)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Jan J Piek (JJ)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Justin E Davies (JE)

Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom.

Javier Escaned (J)

Hospital Clinico San Carlos IDISSC and Universidad Complutense de Madrid, Madrid, Spain.

William Wijns (W)

The Lambe Institute for Translational Medicine and Curam, National University of Ireland Galway, Galway, Ireland; Saolta University Healthcare Group, University College Hospital Galway, Galway, Ireland.

Yoshinobu Onuma (Y)

Department of Cardiology, National University of Ireland Galway, Galway, Ireland.

Patrick W Serruys (PW)

Department of Cardiology, National University of Ireland Galway, Galway, Ireland; Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: patrick.w.j.c.serruys@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH